Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Corvus Pharmaceuticals (CRVS) Receivables - Other: 2022-2023

Historic Receivables - Other for Corvus Pharmaceuticals (CRVS) over the last 2 years, with Dec 2023 value amounting to $26,000.

  • Corvus Pharmaceuticals' Receivables - Other was N/A to $70,000 in Q3 2024 from the same period last year, while for Sep 2024 it was $70,000, marking a year-over-year change of. This contributed to the annual value of $26,000 for FY2023, which is 95.58% down from last year.
  • As of FY2023, Corvus Pharmaceuticals' Receivables - Other stood at $26,000, which was down 95.58% from $588,000 recorded in FY2022.
  • In the past 5 years, Corvus Pharmaceuticals' Receivables - Other registered a high of $588,000 during FY2022, and its lowest value of $26,000 during FY2023.
  • Over the past 2 years, Corvus Pharmaceuticals' median Receivables - Other value was $307,000 (recorded in 2022), while the average stood at $307,000.
  • Data for Corvus Pharmaceuticals' Receivables - Other shows a maximum YoY tumbled of 95.58% (in 2023) over the last 5 years.
  • Yearly analysis of 2 years shows Corvus Pharmaceuticals' Receivables - Other stood at $588,000 in 2022, then plummeted by 95.58% to $26,000 in 2023.